Paroxetine associated hepatotoxicity: A report of 3 cases and a review of the literature

Pharmacopsychiatry

Volumn 35, Issue 3, 2002, Pages 112-115

  Azaz Livshits, Tanya ^a   Hershko, A ^a   Ben Chetrit, E ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BENAZEPRIL; BROTIZOLAM; CAPTOPRIL; CHLORAL HYDRATE; DIGOXIN; FUROSEMIDE; ISOSORBIDE MONONITRATE; MIANSERIN; PAROXETINE; RANITIDINE; TRAZODONE; VERAPAMIL; WARFARIN;

ADULT; AGED; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; HEPATITIS; HUMAN; HYPONATREMIA; LIVER TOXICITY; MALE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; RISK FACTOR;

AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSIVE DISORDER; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; PAROXETINE; RISK FACTORS;

EID: 0036084226     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-31515     Document Type: Article

References (23)

1. Chronic active hepatitis associated with trazodone therapy
2. Paroxetine and hepatotoxicity
3. The safety profile of paroxetine
4. Trazodone: Review pharmacological properties and therapeutic use in depression and anxiety
5. Concentration-related changes in blood and tissue parameters of hepatotoxicity and their interdependence in rats exposed to bromobenzene and 1,2-dichlorobenzene
6. Atrium and paroxetine-related severe hepatitis
7. Chronic active hepatitis associated with trazodone therapy
8. The pharmacokinetics of paroxetine in renal impairment
9. A comparison of paroxetine and placebo in depressed patients
10. Drug-induced hepatotoxicity
11. Reversible hepatotoxicity of paroxetine in a patient with major depression
12. Pharmacokinetics of selective serotonin reuptake inhibitors
13. Possible association between poor metabolism of mephenytoin and hepatotoxicity caused by Atrium, a fixed combination preparation containing phenobarbital, febarbamate and difebarbamate
14. A review of the metabolism and pharmacokinetics of paroxetine in man
15. A double-blind study of the comparative antidepressant effect of paroxetine and amitriptyline
16. Genetic predisposition to drug-induced hepatotoxicity
17. Trazodone-induced hepatotoxicity and leukonychia
18. Severe hepatitis attributed to paroxetine
19. Leukocytoclastic vasculitis secondary to trazodone treatment
20. Syndrome of inappropriate ADH secretion attributed to the serotonin re-uptake inhibitors, venlafaxine and paroxetine
21. Is therpeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors
22. A placebo-controlled, double blind clinical trial of paroxetine in depressed outpatients
23. New indications for antidepressants